Huijie Zhang

Xuzhou, 221006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Association Between Systemic Inflammation Indices and Recurrence Risk in Primary Budd-Chiari Syndrome.

Association Between Systemic Inflammation Indices and Recurrence Risk in Primary Budd-Chiari Syndrome.

Journal: Journal of inflammation research

Published: November 07, 2025

Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy.

Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy.

Journal: RSC advances

Published: September 02, 2025

Cationic Starch Nanoparticles for Enhancing CpG Oligodeoxynucleotide-Mediated Antitumor Immunity.

Cationic Starch Nanoparticles for Enhancing CpG Oligodeoxynucleotide-Mediated Antitumor Immunity.

Journal: Biomacromolecules

Published: November 13, 2023

Glycogen for lysosome-targeted CpG ODNs delivery and enhanced cancer immunotherapy.

Glycogen for lysosome-targeted CpG ODNs delivery and enhanced cancer immunotherapy.

Journal: International journal of biological macromolecules

Published: July 24, 2023

Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy.

Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy.

Journal: International journal of biological macromolecules

Published: January 25, 2023

Yeast β-D-glucan functionalized graphene oxide for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced antitumor immunity.

Yeast β-D-glucan functionalized graphene oxide for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced antitumor immunity.

Journal: International journal of biological macromolecules

Published: November 18, 2022

Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance.

Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance.

Journal: Acta biomaterialia

Published: June 15, 2021

Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy.

Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy.

Journal: International journal of nanomedicine

Published: June 22, 2020

RBC membrane camouflaged boron nitride nanospheres for enhanced biocompatible performance.

RBC membrane camouflaged boron nitride nanospheres for enhanced biocompatible performance.

Journal: Colloids and surfaces. B, Biointerfaces

Published: December 19, 2019

Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.

Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.

Journal: International journal of nanomedicine

Published: January 19, 2019

BN nanospheres functionalized with mesoporous silica for enhancing CpG oligodeoxynucleotide-mediated cancer immunotherapy.

BN nanospheres functionalized with mesoporous silica for enhancing CpG oligodeoxynucleotide-mediated cancer immunotherapy.

Journal: Nanoscale

Published: July 20, 2018

Extracellular Matrix Component Shelled Nanoparticles as Dual Enzyme-Responsive Drug Delivery Vehicles for Cancer Therapy.

Extracellular Matrix Component Shelled Nanoparticles as Dual Enzyme-Responsive Drug Delivery Vehicles for Cancer Therapy.

Journal: ACS biomaterials science & engineering

Published: July 09, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026